DaVita Inc.
DVA Healthcare Medical Care Facilities
DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow DVA
DaVita Inc. (DVA) EBITDA
DaVita Inc.'s EBITDA for fiscal 2025 was $2.8B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $2.8B. Over the past ten years it has ranged from $1.8B (fiscal 2015) to $2.8B (fiscal 2024); the current reading is higher than 91% of that period. DaVita Inc. ranks 4th of 52 Medical Care Facilities companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $2.8B | (1.97%) |
| FY2024 | $2.8B | 19.85% |
| FY2023 | $2.3B | 13.35% |
| FY2022 | $2.1B | (16.40%) |
| FY2021 | $2.5B | 6.58% |
| FY2020 | $2.3B | 2.95% |
| FY2019 | $2.3B | 6.69% |
| FY2018 | $2.1B | (18.28%) |
| FY2017 | $2.6B | (5.81%) |
| FY2016 | $2.7B | 54.95% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $746.8M | 13.20% |
| Mar 2026 | $659.7M | (11.78%) |
| Dec 2025 | $747.8M | 9.44% |
| Sep 2025 | $683.3M | (4.11%) |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| THC Tenet Healthcare Corporation compare | $5.5B |
| FMS Fresenius Medical Care AG & Co. KGaA compare | $3.9B |
| DVA DaVita Inc. | $2.8B |
| UHS Universal Health Services, Inc. compare | $2.7B |
| EHC Encompass Health Corporation compare | $1.5B |
| ENSG The Ensign Group, Inc. compare | $583.0M |
| PACS PACS Group, Inc. compare | $481.4M |
| CON Concentra Group Holdings Parent, Inc. compare | $458.6M |
| CHE Chemed Corporation compare | $415.9M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on DVA
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement